• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18

Pharma

Traffic light go start restart green light
Pharma

FDA approves GSK, Spero's oral treatment for complicated UTIs

Four years after issuing a CRL, the FDA has signed off on GSK and Spero Therapeutics' Utebzi, an oral drug for complicated urinary tract infections.
Kevin Dunleavy Jun 17, 2026 3:20pm
yellow light street light traffic pause slow delay

Verastem mulls options on approved asset in pancreatic cancer

Jun 17, 2026 3:00pm
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
A shot from GSKs Carry On ad for Exdensur showing women walking toward the sea and the product logo

GSK runs first DTC ad for would-be asthma blockbuster Exdensur

Jun 17, 2026 11:55am
ASCO 2026 showed that precision oncologys next challenge is translation

Precision oncology’s next challenge is translation

Brought to you by Thermo Fisher Scientific
Novo Nordisk

Novo's security breach claimed by dual hacking groups: reports

Jun 17, 2026 11:45am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings